This inventor holds 7 USPTO granted patents, plus 4 CIPO patents and 2 EPO patents. Top assignee: Wyeth. Active years: 2010-2014.
Location History:
- Edison, NJ (US) (2010 - 2014)
- West Lafayette, IN (US) (2014)
Company Filing History:
Years Active: 2010-2014
Title: Innovations by Inventor Mohamed Ghorab
Introduction
Mohamed Ghorab is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize micronized tanaproget. With a total of 7 patents to his name, Ghorab's work has implications for various medical treatments.
Latest Patents
Ghorab's latest patents include innovative compositions containing micronized tanaproget prepared by wet granulation. These pharmaceutical compositions are designed for use in contraception and hormone replacement therapy. They also address conditions such as uterine myometrial fibroids, benign prostatic hypertrophy, and various hormone-dependent tumors. Another patent focuses on the methods of preparing these compositions, which can also include ingredients like microcrystalline cellulose and magnesium stearate. The versatility of these compositions extends to stimulating food intake, showcasing their potential in multiple therapeutic areas.
Career Highlights
Ghorab is currently associated with Wyeth, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing medical treatments that improve patient outcomes. His innovative approach to drug formulation has garnered attention in the scientific community.
Collaborations
Throughout his career, Ghorab has collaborated with esteemed colleagues, including Arwinder Singh Nagi and Ramarao S Chatlapalli. These collaborations have further enriched his research and development efforts.
Conclusion
In summary, Mohamed Ghorab is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform medical treatments. His contributions are vital in addressing various health conditions, and his ongoing research continues to pave the way for future innovations.